Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033241
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2002-04-09
Brief Title:
Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2004-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2002-04-09
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-08
Last Update Post Date:
2018-01-10
Last Update Post Date Type:
ACTUAL